Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (36K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Storck, T
Right arrow Articles by Seeburg, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Storck, T
Right arrow Articles by Seeburg, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 4594-4596

Footnote

Rapid construction in yeast of complex targeting vectors for gene manipulation in the mouse

Rapid construction in yeast of complex targeting vectors for gene manipulation in the mouse Thorsten Storck* , Ulrich Krüth , Rohini Kolhekar , Rolf Sprengel and Peter H. Seeburg

Center for Molecular Biology (ZMBH), University of Heidelberg, INF 282 and Max-Planck Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg , Germany

Received July 21, 1996 ; Revised and Accepted October 7, 1996 DDBJ/EMBL/GenBank accession nos U63018, U63120

ABSTRACT

Targeting vectors for embryonic stem (ES) cells typically contain a mouse gene segment of >7 kb with the neo gene inserted for positive selection of the targeting event. More complex targeting vectors carry additional genetic elements (e.g. lacZ, loxP, point mutations). Here we use homologous recombination in yeast to construct targeting vectors for the incorporation of genetic elements (GEs) into mouse genes. The precise insertion of GEs into any position of a mouse gene segment cloned in an Escherichia coli /yeast shuttle vector is directed by short recombinogenic arms (RAs) flanking the GEs. In this way, complex targeting vectors can be engineered with considerable ease and speed, obviating extensive gene mapping in search for suitable restriction sites.

Our approach utilizes the high recombination efficiency in yeast which permits the insertion of genetic markers at precise chromosomal positions by gene replacement ( 1 , 2 ). Typically, yeast cells are transformed with a replication incompetent DNA fragment containing a marker gene flanked by sequences homologous to the integration site, which promote two homologous recombination events. To adopt this strategy for our purposes, a mouse gene segment of >7 kb which provides the backbone of a targeting vector for ES cells, isolated from a [lambda] genomic library, is cloned in an Escherichia coli /yeast shuttle vector. In parallel, all GEs to be inserted into the gene segment, including the neo gene and the yeast selection marker URA3, are assembled by cloning into a suitable bacterial plasmid (e.g. the pRAY vectors described below and in Fig. 1 ). The GEs are then collectively flanked by short (200-400 bp) sequences, PCR-derived from a location in the mouse gene segment where GE insertion is desired. These short sequences which direct GE insertion are termed recombinogenic arms (RAs). Finally, to transfer the GEs into the gene segment on the shuttle vector, the entire GE cassette flanked by RAs is released from the bacterial vector and transfected as donor DNA into yeast cells together with the recombinant shuttle vector as the recipient (Fig. 1 ). Homologous recombinants are selected by URA and plasmids from selected colonies are then transferred to E.coli . Transfer to E.coli is necessary because not all copies of the recombinant shuttle vector in a yeast cell undergo homologous recombination. It also facilitates plasmid growth for further DNA analysis.


Figure 1 . Construction in yeast of complex ES cell targeting vectors. ( A ) Donor DNA [for assembly see (B)] consisting of genetic elements (GEs) including selection markers, flanked by recombinogenic arms (RAs) is co-transformed into yeast with a shuttle vector carrying a mouse gene segment (large open box) as the recipient DNA. The origin of the RAs in the gene segment is indicated by matching symbols. Homologous recombination in yeast is directed by the RAs and leads to the position specific integration of the GEs in the targeting vector. ( B ) Assembly by cloning of donor DNA in the bacterial vector pRAY-1 which contains the neo gene under the thymidine kinase promoter for ES cell selection and the URA3 gene for selection of yeast recombinants. The two marker genes are collectively flanked by loxP sites (filled triangles) and four unique restriction sites for the convenient cloning of RAs and GEs and for the release ( Sfi I- Not I) of the entire donor DNA. The non-homologous Sfi I and Not I termini in the donor DNA are lost during recombination. Abbreviations are: ori, bacterial origin of replication; amp, ampicillin resistance gene; TRP1, tryptophan selection marker; ARS1, autonomously replicating sequence; CEN1, centromer element.

In our experiments (Table 1 ), yeast strain DF5 ( 3 ) was co-transformed by lithium acetate ( 4 ) with 500 ng each of the shuttle vector YCplac22 ( 5 ) containing gene segments of ~7 kb and of donor DNA flanked by 200-400 bp RAs of sequence identity (or near identity if containing point mutations) to the particular mouse gene segment in the shuttle vector. Typically, out of 4000 Trp + transformants, 30-50 survived URA selection. In all survivors, the GEs including URA3 were inserted via homologous recombination at the selected position, as determined by DNA sequencing and restriction analysis (see below). Using this procedure, we targeted into gene segments GEs ranging from 1 to 5 kb and also introduced point mutations simultaneously via the RAs. The recombination frequency in these experiments was ~1% (Table 1 ). This efficiency was reduced with RAs of only 25 bp in length, and no recombinants were obtained when these 25 bp RAs carried short, non-homologous 5' extensions from a polylinker (Table 1 ).

Table 1 . Efficiency of gene replacement by homologous recombination in yeast
Exp.

Recipient

Donor DNA (bp)

Replaced seq.

Homologous recombination

no.

vector

5'-RA

GEs

3'-RA

in targeted gene (bp)

(% transformants)

1

YCplac22a

317

4420

236

303

1.1

2

YCplac22a

309

4836

378

118

2.1

3

YCplac22b

309

4420

271

1

1.7

4

YCplac22a

309

3693

377

1

0.4

5

YCplac22a

25

1125

25

0

0.3

6

YCplac22a

25+Not

1125

25+Not

0

0.0

The columns show from left to right the number of independent experiments, the recipient recombinant shuttle vector, the donor DNAs with the length (bp) of 5'-RAs, GEs and 3'-RAs, the sequence length in the mouse gene segment replaced by the GEs (0 bp, insertion), and the frequency of homologous recombination expressed as % transformants. Cotransformation of yeast (for details see text) was with different donor DNAs and two recombinant shuttle vectors, YCplac22a and YCplac22b, each containing a different mouse gene segment (7.0 and 7.3 kb, respectively). The GEs consisted of combinations of the URA3 marker, neo, and several transcriptional control elements, except for experiments 5 and 6 in which URA3 was the only GE. Donor DNA was assembled in and released from pRAY-1 (experiments1-3), from pRAY-2 (see text, experiment 4) or was entirely PCR-derived (experiments 5 and 6). Experiments 5 and 6 differ in that the 25 bp RAs in the latter additionally contain a Not I-generated overhang at both ends which was generated by cloning and excising this donor DNA from a plasmid.

No rearrangement of mouse gene segments was observed in the recombined targeting vectors, since restriction patterns of recombinant shuttle vectors did not change after growth in yeast for 48 generations (data not shown). Recombined targeting vectors grown in E.coli were further identified by comparison of restriction patterns with the genomic clone (Fig. 2 ) and by sequence analysis of the DNA flanking the introduced GEs (not shown). In all cases examined, the GEs had been inserted precisely as predicted.


Figure 2 . Analysis of a recombined targeting vector. ( A ) Map of all Eco RI sites in a 4.4 kb donor DNA of several genetic elements (GEs) with flanking recombinogenic arms (RAs, hatched and filled boxes) and in a 7.3 kb gene segment (open box) in YCplac22 (YCplac22b, Table 1). Broken lines indicate the insertion point of the GEs in the mouse gene segment. Numbers show Eco RI fragment sizes (kb) after GE insertion. The arrows are primers for the PCR analysis of the recombination event in yeast. ( B ) Agarose gel displaying the PCR products specific for recombination within the 5'-RA (lane 1) and 3'-RA (lane 2) sequences in a recombined targeting vector from a yeast colony (10). The gel also resolves Eco RI digests of YCplac22b carrying a gene segment before (lane 3) and after (lane 4) recombination-mediated GE insertion.

To facilitate the cloning steps involved in the assembly of GEs and RAs, we designed the vector pRAY-1 (Fig. 1 B) which carries the URA3 gene and the neo selection marker for later use in ES cells. The dual selection box is flanked by four unique restriction sites for the insertion of GEs and RAs, and by loxP elements which permit Cre recombinase-mediated removal ( 6 ) of the selection genes after successful targeting. Sfi I- Not I release of the donor DNA from pRAY-1 leaves at the very ends of the RAs a few base pairs, that are not homologous to targeted sequences. With RAs of >200 bp, these non-homologous termini did not interfere with homologous recombination by which they were removed, as revealed by DNA sequence analysis.

To provide an alternative for the URA selection in yeast, we constructed the vector pRAY-2 which lacks the URA3 gene but contains a neo gene modified to confer resistence to E.coli as well as ES cells ( 7 ). After cotransformation into yeast with 500 ng of recombinant shuttle vector and 500 ng of donor DNA from pRAY-2, plasmid DNA prepared from ~2000 pooled Trp + colonies was electroporated into E.coli strain XL1Blue (Stratagene). Approximately 10 bacterial transformants harbouring the recombined targeting vector could be selected on agar plates containing 15 [mu]g/ml kanamycin (Table 1 ). Thus, the pRAY vectors provide selection markers for the recombination event either in yeast (URA3) or in E.coli (neo). Moreover, due to the high efficiency of homologous recombination (~1% with RAs of >200 bp), yeast tranformants can be screened directly by PCR for the successful targeting, precluding the use of a selection marker in the donor DNA.

The use of homologous recombination in yeast for the targeted insertion of GEs in a large mouse gene segment is in accordance with the widely used recombination strategy for targeting yeast genes ( 1 , 2 ) and for manipulating ( 8 , 9 ) or rescuing ( 10 ) genes cloned in yeast artificial chromosomes. The method proved advantageous in our hands for the construction of several complex gene targeting vectors, each within 3 weeks which compares favorably with the several months required for bacterial cloning. It should be of general use for manipulating DNA sequences without taking recourse to suitable restriction sites.

ACKNOWLEDGEMENTS

We thank J. Jerecic for experimental input, and Dr. S. Jentsch and T. Mayer for helpful discussions and for plasmid YCplac22 and yeast strain DF5. The sequences of plasmids pRAY-1 and pRAY-2 are available from DDBJ/EMBL/GenBank (accession nos U63018 and U63120). Supported, in part, by Sonderforschungsbereich grant 317 and the German Chemical Industry.

REFERENCES

1 Rothstein,R. (1991) Methods Enzymol. 194, 281-301.

2 Lorenz,M.C. et al. (1995) Gene 158, 113-117.

3 Finley,D., Özkaynak,E. and Varshavsky,A. (1987) Cell 48, 1035-1046.

4 Ausubel,F.M. et al. (eds) Current Protocols in Molecular Biology,Vol. II. John Wiley and Sons, Inc., Massachusetts, Chapter 13, pp. 13.7.1-13.7.2.

5 Gietz,R.D. and Sugino,A. (1988) Gene 74, 527-534.

6 Gu,H., Zou,Y.R. and Rajewsky,K. (1993) Cell 73, 1155-1164.

7 Al-Qahtani,A. and Mensa-Wilmot,K. (1996) Nucleic Acids Res. 24, 1173-1174.

8 Riley,J.H. et al. (1992) Nucleic Acids Res. 20, 2971-2976.

9 Reeves,R.H. et al. (1992) Methods Enzymol. 216, 584-603.

10 Bradshaw,M.S. et al. (1995) Nucleic Acids Res. 23, 4850-4856.


Return

* To whom correspondence should be addressed. Tel: +49 6221 54 6859; Fax: +49 6221 54 5894; Email: storck@sun0.urz.uni-heidelberg.de
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. R. Thakker, F. Natt, D. Husken, R. Maier, M. Muller, H. van der Putten, D. Hoyer, and J. F. Cryan
Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference
PNAS, December 7, 2004; 101(49): 17270 - 17275.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. Houghtaling, C. Timmers, M. Noll, M. J. Finegold, S. N. Jones, M. S. Meyn, and M. Grompe
Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice
Genes & Dev., August 15, 2003; 17(16): 2021 - 2035.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Ciani, A. Patel, N. D. Allen, and C. ffrench-Constant
Mice Lacking the Giant Protocadherin mFAT1 Exhibit Renal Slit Junction Abnormalities and a Partially Penetrant Cyclopia and Anophthalmia Phenotype
Mol. Cell. Biol., May 15, 2003; 23(10): 3575 - 3582.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. H. Soderling, L. K. Langeberg, J. A. Soderling, S. M. Davee, R. Simerly, J. Raber, and J. D. Scott
Loss of WAVE-1 causes sensorimotor retardation and reduced learning and memory in mice
PNAS, February 18, 2003; 100(4): 1723 - 1728.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
L. van der Weyden, D. J. Adams, and A. Bradley
Tools for targeted manipulation of the mouse genome
Physiol Genomics, December 3, 2002; 11(3): 133 - 164.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. C. Fuchs, H. Doheny, H. Faulkner, A. Caputi, R. D. Traub, A. Bibbig, N. Kopell, M. A. Whittington, and H. Monyer
Genetically altered AMPA-type glutamate receptor kinetics in interneurons disrupt long-range synchrony of gamma oscillation
PNAS, March 13, 2001; 98(6): 3571 - 3576.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
J. L. Hartley, G. F. Temple, and M. A. Brasch
DNA Cloning Using In Vitro Site-Specific Recombination
Genome Res., November 1, 2000; 10(11): 1788 - 1795.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
M. R. PICCIOTTO and K. WICKMAN
Using Knockout and Transgenic Mice to Study Neurophysiology and Behavior
Physiol Rev, October 1, 1998; 78(4): 1131 - 1163.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (36K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Storck, T
Right arrow Articles by Seeburg, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Storck, T
Right arrow Articles by Seeburg, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?